Skip to main content
. 2021 Oct 23;13(11):3744. doi: 10.3390/nu13113744

Table 1.

Pomegranate/ellagitannins/urolithins-based studies in relation to neuroprotection.

Compound In Vitro Model In Vivo Model Dose/
Duration
Neuroprotective Roles Reference
Ellagic acid (EA), Urolithins A, B, C and D Human umbilical vein endothelial cells (HUVECs) - 10 µM Anti-atherogenic effects Mele et al., 2016 [190]
Punicalagin Primary mixed glial cells, organotypic hippocampal slice cultures - 5–40 µM Anti-inflammatory effects Olajide et al., 2014 [191]
Urolithin A/B - C. elegans 10 µg/mL Anti-Aβ fibrillation effects Yuan et al., 2016 [171]
Pomegranate (freeze dried) SK-N-SH cells - 50–200
ppm
Anti-inflammatory effects
Inhibition of BACE1 and
Velagapudi et al., 2016 [192]
Pomegranate- (pulp hydroalcoholic extract juice, pulp aqueous extract) PC12 - 800 μg/mL
6 h/12 h
Antioxidant activity
Anti-apoptogenic activity
Forouzanfar et al., 2013 [193]
Pomegranate peel extract - Male C57Bl/6 mice 800 mg/kg/day for 35 days Reduction of Aβ plaque density, lipid peroxidation
Anti-inflammatory effects
Increase in the expression of neurotrophin BDNF
Morzelle et al., 2016 [194]
Pomegranate extract PC12 mice 800 mg/kg/day Antioxidant effects
Inhibition of Aβ-induced learning and memory deficiency
Choi et al., 2015 [195]
Pomegranate (freeze dried) - Transgenic mice APPsw/Tg2576 4% fruit diet Antioxidant activity Subash et al., 2014 [196]
Urolithin A/B MCF7 - 40 µM Estrogenic and anti-estrogenic activity Larrosa et al., 2006 [140]
Urolithin A/B SK-N-MC - 10 μM Antiglycative activity Verzelloni et al., 2011 [197]
Urolithins A/B BV2 murine microglia and SH-SY5Y non-contact, co-culture model - 10 μM Anti-neuroinflammatory activity DaSilva et al., 2017 [198]
Urolithins A/B BV2 murine microglia - 3–30 μM Anti-neuroinflammatory activity Xu et al., 2018 [199]